1. Chromosomes and Gene Expression
  2. Cancer Biology
Download icon

Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer

  1. Thomas K Ni
  2. Charlotte Kuperwasser  Is a corresponding author
  1. Tufts University, United States
Research Article
  • Cited 15
  • Views 1,668
  • Annotations
Cite this article as: eLife 2016;5:e14730 doi: 10.7554/eLife.14730

Abstract

Genetic mutation, chromosomal rearrangement and copy number amplification are common mechanisms responsible for generating gain-of-function, cancer-causing alterations. Here we report a new mechanism by which premature cleavage and polyadenylation (pPA) of RNA can produce an oncogenic protein. We identify a pPA event at a cryptic intronic poly(A) signal in MAGI3, occurring in the absence of local exonic and intronic mutations. The altered mRNA isoform, called MAGI3pPA, produces a truncated protein that acts in a dominant-negative manner to prevent full-length MAGI3 from interacting with the YAP oncoprotein, thereby relieving YAP inhibition and promoting malignant transformation of human mammary epithelial cells. We additionally find evidence for recurrent expression of MAGI3pPA in primary human breast tumors but not in tumor-adjacent normal tissues. Our results provide an example of how pPA contributes to cancer by generating a truncated mRNA isoform that encodes an oncogenic, gain-of-function protein.

Article and author information

Author details

  1. Thomas K Ni

    Department of Developmental, Chemical and Molecular Biology, Tufts University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Charlotte Kuperwasser

    Department of Developmental, Chemical and Molecular Biology, Tufts University, Boston, United States
    For correspondence
    Charlotte.kuperwasser@tufts.edu
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animals were handled according to the animal protocol approved by the Tufts University Institutional Animal Care and Use Committee. The approval number for animal research is A-3775-01.

Human subjects: Disease-free human breast tissue was obtained in compliance with the laws and institutional guidelines as approved by the Tufts Medical Center Institutional Review Board Committee. The approval number for human subject research is 00004517. The tissue was obtained from patients undergoing elective reduction mammoplasty. De-identified breast tissue was utilized for this study, and for this reason informed consent was not required.

Reviewing Editor

  1. Jonathan A Cooper, Fred Hutchinson Cancer Research Center, United States

Publication history

  1. Received: January 26, 2016
  2. Accepted: May 19, 2016
  3. Accepted Manuscript published: May 20, 2016 (version 1)
  4. Accepted Manuscript updated: May 20, 2016 (version 2)
  5. Version of Record published: June 13, 2016 (version 3)

Copyright

© 2016, Ni & Kuperwasser

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,668
    Page views
  • 309
    Downloads
  • 15
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)